Meanwhile, Kim and colleagues observed that mice bearing the mouse glioma cell line GL261 had a higher percentage of TIM-3 positivity on brain-infiltrating CD4+ and CD8+ T cells compared to non-tumor–bearing control mice [100]. This evidence concerns the gene CD8A and glioma.